Abstract
Six prospective real-world studies of antihypertensive treatment with valsartan-centric regimens were pooled to: (1) examine the effectiveness of ∼90 days of second- or later-line valsartan treatment in hypertensive patients with known comorbidities; and (2) identify physician- and patient-related determinants associated with systolic (SBP) and diastolic blood pressure (DBP) outcomes in these patients. A pooled analysis was performed of an evaluable sample of 11,999 hypertensive patients with known comorbidities treated ∼90 days with valsartan-centric regimens. We applied hierarchical linear and logistic regression models to identify determinants of blood pressure (BP) outcomes and a potential physician class effect. Valsartan regimens resulted in mean (SD) SBP and DBP reductions of 18.0 (15.8) mmHg and 9.5 (10.1) mmHg, respectively, at ∼90 days, yielding SBP, DBP and combined SBP/DBP control rates of 44.0%, 67.2% and 39.3%, respectively. About a quarter of the variance in 90 day BP values was attributable to a physician class effect. BP outcomes declined with physicians' increasing years in practice and being male. At the patient level, BP outcomes declined with SBP and DBP at diagnosis; diabetes; higher cholesterol and BMI; l...Continue Reading
References
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Nov 6, 2001·Annals of Internal Medicine·L S PhillipsC S Barnes
Jul 20, 2002·Journal of Hypertension·Robert H FagardXavier Warling
Jun 5, 2003·Journal of Hypertension·UNKNOWN European Society of Hypertension-European Society of Cardiology Guidelines Committee
Jun 28, 2003·BMJ : British Medical Journal·M R LawR E Jordan
Feb 16, 2005·Annals of Internal Medicine·Niteesh K ChoudhryStephen B Soumerai
Oct 7, 2005·Journal of Hypertension·Boris Lg Van WijkAnthonius de Boer
Jan 25, 2006·Hypertension·Eni C OkonofuaBrent M Egan
Apr 9, 2009·The Annals of Pharmacotherapy·Patricia Van der NiepenIvo Abraham
Jun 10, 2010·Journal of Hypertension·Josep RedónPedro Aranda
Oct 5, 2010·The Journal of Clinical Hypertension·Peter BramlageMartin Thoenes
Apr 15, 2011·Vascular Health and Risk Management·Ivo AbrahamStefaan Vancayzeele
Jun 15, 2011·The Annals of Pharmacotherapy·Robert LinsIvo Abraham
Sep 29, 2011·Archives of Cardiovascular Diseases·Robert LinsIvo Abraham
Apr 28, 2012·BMC Family Practice·Rickard EkesboLennart Johansson
Jan 29, 2013·BMC Family Practice·Qian ChenShanzhu Zhu
Dec 31, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Lorenzo VillaIvo Abraham
Aug 31, 2018·European Heart Journal·Bryan WilliamsUNKNOWN ESC Scientific Document Group